Screener
Amphastar Pharmaceuticals AMPH Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's total assets?
- Amphastar Pharmaceuticals (AMPH) reported total assets of $1.74B in Q2 2026.
- How has Amphastar Pharmaceuticals's total assets changed year-over-year?
- Amphastar Pharmaceuticals's total assets increased by 8.0% year-over-year, from $1.62B to $1.74B.
- What is the long-term trend for Amphastar Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's total assets has grown at a 20.9% compound annual growth rate (CAGR), from $631.24M to $1.63B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Amphastar Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude